减重手术后阿片类药物的处方与消耗:多中心前瞻性队列研究
该多中心前瞻性队列纳入351例成人腹腔镜减重手术患者,比较出院时阿片类处方量与出院后30天内自报消耗量。处方中位15片(112.5 MME)显著高于消耗中位1片(7.5 MME)(p<0.001),37%患者未用任何阿片类,78.5%处方片剂未使用。男性、较高BMI、术前阿片使用、当前吸烟、较高抑郁评分、吻合术式及处方片数预测消耗增加。
要点
- 减重术后出院阿片类处方量远高于实际消耗,多数片剂未使用。
- 37%患者出院后未使用任何阿片类药物。
- 男性、吸烟、术前阿片使用、抑郁评分高及吻合术式者消耗更多。
核心结论
- 减重手术患者出院时开具的大多数阿片类片剂未被消耗。
- 患者与手术相关因素可能预测出院后阿片类消耗。
- 个体化出院后镇痛策略(最少或不用阿片类)可能可行,需进一步研究。
研究设计与样本
- 多中心前瞻性队列研究,纳入351例≥18岁接受腹腔镜减重手术的成人患者。
- 术前评估包括人口学与患者报告指标,手术及围术期信息来自病历。
- 出院后30天内每周自报阿片类消耗,采用Wilcoxon符号秩检验比较处方与消耗片数,零膨胀负二项回归识别预测因素。
主要发现
- 出院阿片类处方中位15片(IQR 15-16),112.5 MME(IQR 80-112.5)。
- 患者自报消耗中位1片(IQR 0-5),7.5 MME(IQR 0-37.5),处方显著高于消耗(p<0.001)。
- 37%患者出院后未使用任何阿片类,78.5%处方片剂未使用。
- 消耗增加与男性(IRR 1.54 [95%CI 1.14 to 2.07])、较高BMI(1.03 [95%CI 1.01 to 1.05])、术前阿片使用(1.48 [95%CI 1.04 to 2.10])、当前吸烟(2.32 [95%CI 1.44 to 3.72])、较高PROMIS-29抑郁评分(1.03 [95%CI 1.01 to 1.04])、吻合术式(1.33 [95%CI 1.01 to 1.75])及处方片数(1.04 [95%CI 1.01 to 1.06])相关。
临床怎么用
- 减重术后出院可考虑个体化镇痛策略,减少或避免常规阿片类处方。
- 对男性、吸烟、术前阿片使用、抑郁评分高及吻合术式患者可适当关注镇痛需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In the current opioid crisis, bariatric surgical patients are at increased risk of harms related to postoperative opioid overprescribing. This study aimed to assess the extent to which opioids prescribed at discharge after bariatric surgery are consumed by patients. METHODS: This multicenter prospective cohort study included adult patients (≥ 18yo) undergoing laparoscopic bariatric surgery. Preoperative assessments included demographics and patient-reported measures. Information regarding surgical and perioperative care interventions (including discharge prescriptions) was obtained from medical records. Self-reported opioid consumption was assessed weekly up to 30 days post-discharge. Number of opioid pills prescribed and consumed was compared using Wilcoxon signed-rank test. Zero-inflated negative binomial regression was used to identify predictors of post-discharge opioid consumption. RESULTS: We analyzed 351 patients (mean age 44 ± 11 years, BMI 45 ± 8.0 kg/m2, 77% female, 71% sleeve gastrectomy, length of stay 1.6 ± 0.6 days). The quantity of opioids prescribed at discharge (median 15 pills [IQR 15-16], 112.5 morphine milligram equivalents (MMEs) [IQR 80-112.5]) was significantly higher than patient-reported consumption (median 1 pill [IQR 0-5], 7.5 MMEs [IQR 0-37.5]) (p < 0.001). Overall, 37% of patients did not take any opioids post-discharge and 78.5% of the opioid pills prescribed were unused. Increased post-discharge opioid consumption was associated with male sex (IRR 1.54 [95%CI 1.14 to 2.07]), higher BMI (1.03 [95%CI 1.01 to 1.05]), preoperative opioid use (1.48 [95%CI 1.04 to 2.10]), current smoking (2.32 [95%CI 1.44 to 3.72]), higher PROMIS-29 depression score (1.03 [95% CI 1.01 to 1.04]), anastomotic procedures (1.33 [95%CI 1.01 to 1.75]), and number of pills prescribed (1.04 [95%CI 1.01 to 1.06]). CONCLUSION: This study supports that most opioid pills prescribed to bariatric surgery patients at discharge are not consumed. Patient and procedure-related factors may predict opioid consumption. Individualized post-discharge analgesia strategies with minimal or no opioids may be feasible and should be further investigated in future research.
引用
- Jain S, Lapointe-Gagner M, Alali N, et al. Prescription and consumption of opioids after bariatric surgery: a multicenter prospective cohort study. Surg Endosc. 2023. PMID: 37460817. doi:10.1007/s00464-023-10265-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。